MiniMed (MMED) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $17.49, -2.83% vs the prior close of $18.00.
- Volume 21.45M shares, 3.1x its 50-day average (heavy).
- New SEC filings: 4 (Oct 16, 2026), 4 (Oct 16, 2026), 4 (Oct 16, 2026), 3 (Oct 16, 2026), SCHEDULE 13G/A (Oct 16, 2026), 4 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
MMED dips 2.8% to $17.49 on 3.1x normal volume. Closed at $17.49, -2.83% vs the prior close of $18.00. Day range $17.38–$18.00, opened at $17.70.
MMED daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MMED dips 2.8% to $17.49 on 3.1x normal volume
- Closed at $17.49, -2.83% vs the prior close of $18.00. Day range $17.38–$18.00, opened at $17.70.
- Volume was 21.45M shares, 3.1x its 50-day average of 6.90M — unusually heavy trading.
- Price is -14.5% vs its 50-day average ($20.45).
- 52-week range $10.65–$24.43; today's close sits at 50% of that range, 28.4% below the 52-week high.
Oct 15, 2026 — MMED jumps 7.1% to $18.00 on 4.4x normal volume
- Closed at $18.00, +7.08% vs the prior close of $16.81. Day range $16.60–$18.08, opened at $16.65.
- Volume was 27.73M shares, 4.4x its 50-day average of 6.36M — unusually heavy trading.
- Price is -12.1% vs its 50-day average ($20.47).
- 52-week range $10.65–$24.43; today's close sits at 53% of that range, 26.3% below the 52-week high.
Oct 14, 2026 — MMED slides 8.6% to $16.81, a 1-month low on 13.4x normal volume
- Closed at $16.81, -8.64% vs the prior close of $18.40. Day range $16.56–$18.40, opened at $18.17.
- Volume was 67.62M shares, 13.4x its 50-day average of 5.03M — unusually heavy trading.
- Price is -17.9% vs its 50-day average ($20.48).
- 52-week range $10.65–$24.43; today's close sits at 45% of that range, 31.2% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — MMED dips 2.1% to $18.40, a 1-month low on 7.7x normal volume
- Closed at $18.40, -2.13% vs the prior close of $18.80. Day range $18.37–$19.35, opened at $19.14.
- Volume was 33.61M shares, 7.7x its 50-day average of 4.38M — unusually heavy trading.
- Price is -10.4% vs its 50-day average ($20.53).
- 52-week range $10.65–$24.43; today's close sits at 56% of that range, 24.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — MMED slides 4.6% to $18.80, a 1-month low on 10.7x normal volume
- Closed at $18.80, -4.62% vs the prior close of $19.71. Day range $18.46–$19.49, opened at $18.87.
- Volume was 38.55M shares, 10.7x its 50-day average of 3.62M — unusually heavy trading.
- Price is -8.5% vs its 50-day average ($20.54).
- 52-week range $10.65–$24.43; today's close sits at 59% of that range, 23.0% below the 52-week high.
Oct 9, 2026 — MMED dips 0.5% to $19.71 on 5.6x normal volume
- Closed at $19.71, -0.45% vs the prior close of $19.80. Day range $19.47–$20.15, opened at $19.79.
- Volume was 18.40M shares, 5.6x its 50-day average of 3.27M — unusually heavy trading.
- Price is -4.0% vs its 50-day average ($20.53).
- 52-week range $10.65–$24.43; today's close sits at 66% of that range, 19.3% below the 52-week high.
Oct 8, 2026 — MMED jumps 3.6% to $19.80 on 8.2x normal volume
- Closed at $19.80, +3.61% vs the prior close of $19.11. Day range $18.94–$19.83, opened at $19.08.
- Volume was 23.34M shares, 8.2x its 50-day average of 2.83M — unusually heavy trading.
- Price is -3.4% vs its 50-day average ($20.50).
- 52-week range $10.65–$24.43; today's close sits at 66% of that range, 19.0% below the 52-week high.
Oct 7, 2026 — MMED dips 2.7% to $19.11, a 1-month low on 3.6x normal volume
- Closed at $19.11, -2.70% vs the prior close of $19.64. Day range $19.03–$19.64, opened at $19.57.
- Volume was 9.62M shares, 3.6x its 50-day average of 2.68M — unusually heavy trading.
- Price is -6.6% vs its 50-day average ($20.47).
- 52-week range $10.65–$24.43; today's close sits at 61% of that range, 21.8% below the 52-week high.
Oct 6, 2026 — MMED dips 2.6% to $19.64 on 6.4x normal volume
- Closed at $19.64, -2.58% vs the prior close of $20.16. Day range $19.40–$20.00, opened at $19.79.
- Volume was 15.51M shares, 6.4x its 50-day average of 2.41M — unusually heavy trading.
- Price is -3.9% vs its 50-day average ($20.44).
- 52-week range $10.65–$24.43; today's close sits at 65% of that range, 19.6% below the 52-week high.
Oct 5, 2026 — MMED rises 2.3% to $20.16 on 7.2x normal volume
- Closed at $20.16, +2.34% vs the prior close of $19.70. Day range $19.03–$20.17, opened at $19.69.
- Volume was 15.35M shares, 7.2x its 50-day average of 2.12M — unusually heavy trading.
- Price is -1.2% vs its 50-day average ($20.40).
- 52-week range $10.65–$24.43; today's close sits at 69% of that range, 17.5% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — MMED rises 0.5% to $19.70 on 2.3x normal volume
- Closed at $19.70, +0.51% vs the prior close of $19.60. Day range $19.29–$19.98, opened at $19.53.
- Volume was 4.70M shares, 2.3x its 50-day average of 2.04M — unusually heavy trading.
- Price is -3.1% vs its 50-day average ($20.33).
- 52-week range $10.65–$24.43; today's close sits at 66% of that range, 19.4% below the 52-week high.
MMED latest news & SEC filings
Every SEC filing by or about MMED in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hopkins Robert (Bob) received an award of 11,877 shares on Oct 15, 2026; now holds 11,877
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Endicott David J. received an award of 3,374 shares on Oct 15, 2026; now holds 15,169
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bricker Amy received an award of 11,877 shares on Oct 15, 2026; now holds 11,877
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 16, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Medtronic Plc reported an other transaction of 252,813,348 shares on Oct 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.01 — Change in control of the company.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wicks Timothy A received an award of 11,795 shares on Oct 9, 2026; now holds 25,684
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 5, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade MMED
- Last results release: Sep 1, 2026 (8-K Item 2.02). Previous ones: Jun 3, 2026. Based on that rhythm, the next report is likely around Dec 1, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.75% (largest 8.6%).
- Liquidity: about 15.24M shares (≈$266.58M) trade per day on average.
- 52-week position: $17.49 vs a range of $10.65–$24.43 (50% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 13, 2026; 10-Q Sep 8, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
MMED market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 17.70 | 18.00 | 17.38 | 17.49 | 21.45M |
| Oct 15, 2026 | 16.65 | 18.08 | 16.60 | 18.00 | 27.73M |
| Oct 14, 2026 | 18.17 | 18.40 | 16.56 | 16.81 | 67.62M |
| Oct 13, 2026 | 19.14 | 19.35 | 18.37 | 18.40 | 33.61M |
| Oct 12, 2026 | 18.87 | 19.49 | 18.46 | 18.80 | 38.55M |
| Oct 9, 2026 | 19.79 | 20.15 | 19.47 | 19.71 | 18.40M |
| Oct 8, 2026 | 19.08 | 19.83 | 18.94 | 19.80 | 23.34M |
| Oct 7, 2026 | 19.57 | 19.64 | 19.03 | 19.11 | 9.62M |
| Oct 6, 2026 | 19.79 | 20.00 | 19.40 | 19.64 | 15.51M |
| Oct 5, 2026 | 19.69 | 20.17 | 19.03 | 20.16 | 15.35M |
| Oct 2, 2026 | 19.53 | 19.98 | 19.29 | 19.70 | 4.70M |
| Oct 1, 2026 | 19.51 | 19.64 | 19.25 | 19.60 | 3.93M |
| Sep 30, 2026 | 20.07 | 20.12 | 19.44 | 19.47 | 4.02M |
| Sep 29, 2026 | 20.31 | 20.37 | 19.73 | 20.04 | 3.34M |
| Sep 28, 2026 | 19.97 | 20.51 | 19.80 | 20.49 | 3.73M |
| Sep 25, 2026 | 20.75 | 20.75 | 19.71 | 19.98 | 2.55M |
| Sep 24, 2026 | 20.69 | 21.03 | 20.29 | 20.44 | 3.41M |
| Sep 23, 2026 | 21.17 | 21.26 | 20.37 | 20.54 | 2.85M |
| Sep 22, 2026 | 21.68 | 21.69 | 20.99 | 21.20 | 2.80M |
| Sep 21, 2026 | 22.14 | 22.30 | 21.09 | 21.12 | 2.33M |
About MiniMed
MiniMed (MMED) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NORTHRIDGE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2062583.
MMED board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Linnea Burman | Director | Jul 6, 2026 |
| Scott T Cundy | Director | Jul 6, 2026 |
| Que Dallara | Chief Executive Officer | Aug 4, 2026 |
| Glenn A Eisenberg | Director | Mar 11, 2026 |
| David J. Endicott | Director | Jul 6, 2026 |
| D Keith Grossman | Director | Mar 11, 2026 |
| Robert (Bob) Hopkins | Director | Mar 6, 2026 |
| Kevin E Lofton | Director | Mar 11, 2026 |
| Laura Mauri | Director | Mar 6, 2026 |
| Brian Sandstrom | Director | Mar 5, 2026 |
| Brett A. Wall | Director | Mar 6, 2026 |
| Matthew R. Walter | Director | Mar 6, 2026 |
| Timothy A Wicks | Director | Mar 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gillian Chandrasena | SVP, Chief HR Officer | Jul 29, 2026 |
| Que Dallara | Chief Executive Officer | Aug 4, 2026 |
| Ali Dianaty | EVP Ch. Prod. & Tech Officer | Aug 4, 2026 |
| Christopher Eso | President | Mar 5, 2026 |
| John Gyurci | VP, Chief Accounting Officer | Jul 6, 2026 |
| Chad Spooner | EVP, Chief Financial Officer | Jul 29, 2026 |
| Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | Aug 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MMED financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Apr 24, 2026 | $3.10B | $-333.00M | -1.30 | $-197.00M |
| Apr 25, 2025 | $2.71B | $-213.00M | -0.84 | $140.00M |
| Apr 26, 2024 | $2.47B | $-112.00M | -0.44 | $41.00M |
Latest balance sheet: total assets $4.72B, total liabilities $1.10B, cash $207.00M (as of Jul 31, 2026).
MMED earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 1, 2026 | 8-K Item 2.02 (results) | $22.42 |
| Jun 3, 2026 | 8-K Item 2.02 (results) | $14.26 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Glaukos (GKOS)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MMED
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.